Kidney Cancer Subtypes, Tumor Stages May Predict Recurrence, Prognosis
January 30th 2024Real-world data demonstrated that knowing a patient’s stage and subtype of renal cell carcinoma, a type of kidney cancer, may provide cancer teams with the information needed to determine potential prognosis and recurrence risk.
Read More
No Increased Blood-Related Side Effects With Radium-223 in Prostate Cancer
January 27th 2024Patients with metastatic castration-resistant prostate cancer previously treated with external beam radiation therapy did not increase incidence of blood-related side effects with radium-223 compared with the overall population.
Read More
Nubeqa, Hormone Therapy May Reduce Hospitalizations in Prostate Cancer
January 27th 2024Nubeqa plus androgen deprivation therapy and docetaxel to treat patients with metastatic hormone-sensitive prostate cancer lowered hospitalization rates but led to marginally longer lengths of stay compared with those treated with placebo, androgen deprivation therapy and docetaxel.
Read More
Fruzaqla Delays Colorectal Cancer Progression, Prolongs Patient Survival
January 23rd 2024Findings presented at the 2024 Gastrointestinal Cancers Symposium support Fruzaqla’s potential to provide an improved survival benefit and quality of life for those with previously treated metastatic colorectal cancer.
Read More